Shredded Peptide Pen – AOD-9604 + Tesamorelin + MOTS-c 10mg
The Shredded Peptide Pen combines three research peptides associated with metabolic, energy and body-composition pathways: AOD-9604, Tesamorelin and MOTS-c.
The pre-filled 2.6mL pen contains 10mg total peptide blend across 240 precision clicks, providing a convenient multi-dose research format.
Formulation
- AOD-9604: 5mg
- Tesamorelin: 3mg
- MOTS-c: 2mg
- Total peptide blend: 10mg
- Pen volume: 2.6mL
- Clicks: 240
- Approximate total blend per click: 41.7mcg
Based on the formulation ratio, each click contains approximately:
- AOD-9604: 20.85mcg
- Tesamorelin: 12.5mcg
- MOTS-c: 8.33mcg
AOD-9604 Research
AOD-9604 is a modified peptide fragment derived from human growth hormone that has been investigated primarily in relation to lipid metabolism, lipolysis and energy utilisation.
Research interest includes pathways associated with fatty-acid metabolism and adipocyte biology.
Tesamorelin Research
Tesamorelin is a synthetic growth-hormone-releasing hormone analogue researched for its interaction with growth hormone signalling and metabolic pathways.
Research has explored its effects on body composition and adipose-tissue biology, including pathways involving visceral adipose tissue.
MOTS-c Research
MOTS-c is a mitochondria-derived peptide that has attracted research interest in cellular energy metabolism, mitochondrial signalling, glucose metabolism and metabolic adaptation.
It provides a complementary research component to the metabolic pathways associated with AOD-9604 and Tesamorelin.
Why Combine AOD-9604 + Tesamorelin + MOTS-c?
The Shredded blend combines three peptides with different areas of metabolic research interest:
- AOD-9604: lipid metabolism and lipolysis pathways
- Tesamorelin: growth-hormone and body-composition signalling
- MOTS-c: mitochondrial and cellular-energy pathways
This combination provides a research platform for investigating the interaction between lipid metabolism, endocrine signalling, mitochondrial function and body composition.
Research Dosing Reference
The following is the manufacturer-supplied research protocol and is provided for research reference only.
At approximately 41.7mcg total blend per click:
8 clicks
- Approximately 333mcg total blend
- ~167mcg AOD-9604
- ~100mcg Tesamorelin
- ~67mcg MOTS-c
- Approximately 30 doses per pen
10 clicks
- Approximately 417mcg total blend
- ~208.5mcg AOD-9604
- ~125mcg Tesamorelin
- ~83mcg MOTS-c
- Approximately 24 doses per pen
The supplied research protocol describes once-daily administration, with morning/fasted timing commonly referenced.
An alternative higher research reference is 12 clicks, providing approximately 500mcg total blend:
- ~250mcg AOD-9604
- ~150mcg Tesamorelin
- ~100mcg MOTS-c
The supplied protocol describes an example research cycle of 8–12 weeks, with longer protocols and subsequent breaks referenced in some research settings.
These figures are research references only and should not be interpreted as recommended human dosing.
Precision Peptide Pen
The Shredded Pen provides a pre-filled, multi-dose format with 240 precision clicks, allowing controlled quantities of the blended formulation to be selected without manual reconstitution.
MSSPT Formulation Technology
The Peptide Pen incorporates MSSPT technology, designed to support formulation stability by providing controlled protection against environmental factors such as light, oxygen, oxidation and moisture.
This pre-filled format is particularly suited to research environments where consistency and convenient peptide handling are important.
Storage & Handling
The supplied storage guidance specifies storage in a cool, dry environment at controlled room temperature, with temperatures not exceeding approximately 25–30°C.
- Protect from direct sunlight and excessive heat.
- Avoid high humidity and freezing temperatures.
- Keep in the original packaging where possible.
- Keep capped when not in use.
- Keep out of reach of children and pets.
- Inspect the solution before use.
- Do not use if cloudy, discoloured or containing visible particles.
Follow the specific storage instructions supplied with the product.
Important Notice
For research use only. Not intended for human consumption.
AOD-9604, Tesamorelin and MOTS-c are research compounds and should not be represented as an approved treatment for obesity, weight loss, diabetes, metabolic disease or other medical conditions.
The information provided is for research and educational purposes only and does not constitute medical advice or a recommendation for human use.
This product is not intended to diagnose, treat, cure or prevent any disease. Statements regarding research applications have not been evaluated or approved by SAHPRA, the FDA or other regulatory authorities.
Always handle peptide products in accordance with appropriate laboratory safety and research protocols.



